(Q30384899)

21 June 2017

A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis. (English)

1 reference

21 June 2017

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914773%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Ana B. Crujeiras

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914773%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

B Cabia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914773%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

M C Carreira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914773%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

F F Casanueva

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914773%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

24 February 2016

1 reference

21 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914773%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914773%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914773%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

361-376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914773%20AND%20SRC:MED&resulttype=core&format=json

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis

31 May 2020

cites work

1 reference

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

21 January 2018

1 reference

Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach

21 January 2018

1 reference

Global burden of cancer attributable to high body-mass index in 2012: a population-based study

21 January 2018

1 reference

Molecular mechanisms of cancer development in obesity

21 January 2018

1 reference

Adipose tissue as an endocrine organ

21 January 2018

1 reference

Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies.

21 January 2018

1 reference

Differential proteomics of omental and subcutaneous adipose tissue reflects their unalike biochemical and metabolic properties

21 January 2018

1 reference

Subcutaneous and visceral adipose tissue: structural and functional differences

21 January 2018

1 reference

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice

21 January 2018

1 reference

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?

21 January 2018

1 reference

Adipose tissue dysfunction in obesity

21 January 2018

1 reference

Associations between adipokines and obesity-related cancer.

21 January 2018

1 reference

Molecular pathways: adiponectin and leptin signaling in cancer.

21 January 2018

1 reference

21 January 2018

1 reference

Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression

21 January 2018

1 reference

An IL-6 link between obesity and cancer

21 January 2018

1 reference

TNF-alpha in promotion and progression of cancer

21 January 2018

1 reference

Common mechanisms of dysfunctional adipose tissue and obesity-related cancers.

21 January 2018

1 reference

Obesity and cancer: the role of dysfunctional adipose tissue

21 January 2018

1 reference

Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives

21 January 2018

1 reference

Quantitative proteomic analysis of the secretory proteins from rat adipose cells using a 2D liquid chromatography-MS/MS approach

21 January 2018

1 reference

Secretome analysis of rat adipose tissues shows location-specific roles for each depot type

21 January 2018

1 reference

CILAIR-Based Secretome Analysis of Obese Visceral and Subcutaneous Adipose Tissues Reveals Distinctive ECM Remodeling and Inflammation Mediators

21 January 2018

1 reference

Characterization of the human visceral adipose tissue secretome

21 January 2018

1 reference

Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis?

21 January 2018

1 reference

Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.

21 January 2018

1 reference

Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production

21 January 2018

1 reference

Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity

21 January 2018

1 reference

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein

21 January 2018

1 reference

FABP4 attenuates PPARγ and adipogenesis and is inversely correlated with PPARγ in adipose tissues.

21 January 2018

1 reference

Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas

21 January 2018

1 reference

Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression.

21 January 2018

1 reference

Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.

21 January 2018

1 reference

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

21 January 2018

1 reference

Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms

21 January 2018

1 reference

Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI.

21 January 2018

1 reference

Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation

21 January 2018

1 reference

Matrix metalloproteinases: effectors of development and normal physiology

21 January 2018

1 reference

Cloning of cell-specific secreted and surface proteins by subtractive antibody screening

21 January 2018

1 reference

Adipose tissue collagen VI in obesity

21 January 2018

1 reference

Adipocyte-derived endotrophin promotes malignant tumor progression

21 January 2018

1 reference

Collagen VI in cancer and its biological mechanisms

21 January 2018

1 reference

Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization

21 January 2018

1 reference

Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment

21 January 2018

1 reference

Endotrophin in the tumor stroma: a new therapeutic target for breast cancer?

21 January 2018

1 reference

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

21 January 2018

1 reference

Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis

21 January 2018

1 reference

Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis

21 January 2018

1 reference

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

Retraction: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.

21 January 2018

1 reference

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

21 January 2018

1 reference

Nampt: linking NAD biology, metabolism and cancer

21 January 2018

1 reference

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

21 January 2018

1 reference

Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation

21 January 2018

1 reference

Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism.

21 January 2018

1 reference

Matrix metalloproteinases and tumor metastasis

21 January 2018

1 reference

Nampt/Visfatin/PBEF: a functionally multi-faceted protein with a pivotal role in malignant tumors

21 January 2018

1 reference

Nampt/PBEF/visfatin and cancer

21 January 2018

1 reference

Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer.

21 January 2018

1 reference

Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.

21 January 2018

1 reference

A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis

21 January 2018

1 reference

Visfatin promotes cell and tumor growth by upregulating Notch1 in breast cancer

21 January 2018

1 reference

Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells

21 January 2018

1 reference

Anticancer agent CHS-828 inhibits cellular synthesis of NAD.

21 January 2018

1 reference

Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.

21 January 2018

1 reference

The lipocalin protein family: structure and function

21 January 2018

1 reference

The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages.

21 January 2018

1 reference

The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance

21 January 2018

1 reference

Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.

21 January 2018

1 reference

Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans

21 January 2018

1 reference

Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene

21 January 2018

1 reference

Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression

21 January 2018

1 reference

Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells.

21 January 2018

1 reference

Lipocalin 2 in cancer: when good immunity goes bad.

21 January 2018

1 reference

Lipocalin 2: a multifaceted modulator of human cancer

21 January 2018

1 reference

Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis

21 January 2018

1 reference

Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis

21 January 2018

1 reference

No effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancer

21 January 2018

1 reference

Lipocalin 2 performs contrasting, location-dependent roles in APCmin tumor initiation and progression

21 January 2018

1 reference

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells

21 January 2018

1 reference

Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer

21 January 2018

1 reference

The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL.

21 January 2018

1 reference

Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease

21 January 2018

1 reference

Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species

21 January 2018

1 reference

Clinical significance of Neutrophil gelatinase-associated lipocalin(NGAL) expression in primary rectal cancer

21 January 2018

1 reference

Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression

21 January 2018

1 reference

Isolation and characterization of two sialoproteins present only in bone calcified matrix

21 January 2018

1 reference

Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes

21 January 2018

1 reference

Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations.

21 January 2018

1 reference

Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice

21 January 2018

1 reference

Interaction of osteopontin with IL-18 in obese individuals: implications for insulin resistance.

21 January 2018

1 reference

Osteopontin: role in cell signaling and cancer progression

21 January 2018

1 reference

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

21 January 2018

1 reference

Osteopontin as a target for cancer therapy

21 January 2018

1 reference

Role of osteopontin in tumour progression

21 January 2018

1 reference

The role of osteopontin in tumor progression and metastasis in breast cancer

21 January 2018

1 reference

Osteopontin as a therapeutic target for cancer

21 January 2018

1 reference

Functional characterization of stromal osteopontin in melanoma progression and metastasis

21 January 2018

1 reference

Role of osteopontin in the pathophysiology of cancer

21 January 2018

1 reference

Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN.

21 January 2018

1 reference

Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ.

21 January 2018

1 reference

Apelin, a newly identified adipokine up-regulated by insulin and obesity

21 January 2018

1 reference

Apelin, diabetes, and obesity.

21 January 2018

1 reference

Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus

21 January 2018

1 reference

Type 2 diabetes and cancer: what is the connection?

21 January 2018

1 reference

Tumour co-expression of apelin and its receptor is the basis of an autocrine loop involved in the growth of colon adenocarcinomas

21 January 2018

1 reference

Serum levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients.

21 January 2018

1 reference

Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation.

21 January 2018

1 reference

Apelin is a novel angiogenic factor in retinal endothelial cells

21 January 2018

1 reference

Apelin is a potent activator of tumour neoangiogenesis

21 January 2018

1 reference

Apelin promotes lymphangiogenesis and lymph node metastasis.

21 January 2018

1 reference

Apelin levels are higher in obese patients with endometrial cancer

21 January 2018

1 reference

Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases

21 January 2018

1 reference

Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance

21 January 2018

1 reference

Diverse roles of ANGPTL2 in physiology and pathophysiology

21 January 2018

1 reference

Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis.

21 January 2018

1 reference

ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma

21 January 2018

1 reference

ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling

21 January 2018

1 reference

Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis.

21 January 2018

1 reference

The secreted protein ANGPTL2 promotes metastasis of osteosarcoma cells through integrin α5β1, p38 MAPK, and matrix metalloproteinases.

21 January 2018

1 reference

Serum ANGPTL2 levels reflect clinical features of breast cancer patients: implications for the pathogenesis of breast cancer metastasis

21 January 2018

1 reference

Angiopoietin-Like Protein 2 Acts as a Novel Biomarker for Diagnosis and Prognosis in Patients with Esophageal Cancer

21 January 2018

1 reference

Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer

21 January 2018

1 reference

Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids

21 January 2018

1 reference

Chemerin is a novel adipokine associated with obesity and metabolic syndrome

21 January 2018

1 reference

Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism

21 January 2018

1 reference

Towards an integrative approach to understanding the role of chemerin in human health and disease

21 January 2018

1 reference

Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes.

21 January 2018

1 reference

Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-{alpha}.

21 January 2018

1 reference

Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance

21 January 2018

1 reference

Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity

21 January 2018

1 reference

Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis

21 January 2018

1 reference

Increased serum chemerin level promotes cellular invasiveness in gastric cancer: a clinical and experimental study

21 January 2018

1 reference

Overexpression of chemerin was associated with tumor angiogenesis and poor clinical outcome in squamous cell carcinoma of the oral tongue

21 January 2018

1 reference

Increased expression of chemerin in squamous esophageal cancer myofibroblasts and role in recruitment of mesenchymal stromal cells

21 January 2018

1 reference

The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses.

21 January 2018

1 reference

Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice

21 January 2018

1 reference

Human homologs of the Xenopus oocyte cortical granule lectin XL35.

21 January 2018

1 reference

Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall

21 January 2018

1 reference

Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action

21 January 2018

1 reference

Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus.

21 January 2018

1 reference

Omentin plasma levels and gene expression are decreased in obesity.

21 January 2018

1 reference

New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women

21 January 2018

1 reference

Omentin as a novel biomarker of metabolic risk factors

21 January 2018

1 reference

Circulating omentin concentration increases after weight loss

21 January 2018

1 reference

Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells.

21 January 2018

1 reference

Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells.

21 January 2018

1 reference

Haploinsufficient prostate tumor suppression by Nkx3.1: a role for chromatin accessibility in dosage-sensitive gene regulation.

21 January 2018

1 reference

Aberrant expression of intelectin-1 in gastric cancer: its relationship with clinicopathological features and prognosis.

21 January 2018

1 reference

Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer

21 January 2018

1 reference

Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes

21 January 2018

1 reference

The enigmatic cytokine oncostatin m and roles in disease

21 January 2018

1 reference

Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling.

21 January 2018

1 reference

Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines

21 January 2018

1 reference

Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity

21 January 2018

1 reference

Vaspin (serpinA12) in obesity, insulin resistance, and inflammation.

21 January 2018

1 reference

Evaluating vaspin and adiponectin in postmenopausal women with endometrial cancer.

21 January 2018

1 reference

Ceruloplasmin metabolism and function

21 January 2018

1 reference

Plasma ceruloplasmin as a biomarker for obesity: a proteomic approach

21 January 2018

1 reference

Ceruloplasmin is a novel adipokine which is overexpressed in adipose tissue of obese subjects and in obesity-associated cancer cells

21 January 2018

1 reference

Cathepsin D--many functions of one aspartic protease

21 January 2018

1 reference

Cathepsin-D, a key protease in breast cancer, is up-regulated in obese mouse and human adipose tissue, and controls adipogenesis

21 January 2018

1 reference

Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis

21 January 2018

1 reference

Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women

21 January 2018

1 reference

Plasma Osteopontin Levels and Expression in Adipose Tissue Are Increased in Obesity

21 January 2018

1 reference

Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/OBR.12377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26914773%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference